Mergers & Acquisitions Mergers & Acquisitions

Mylan, Upjohn now expect to complete combination in fourth quarter of 2020

By Curtis Eichelberger
  • 28 Jul 2020 10:47
  • 28 Jul 2020 11:05
Mylan and Upjohn now expect to complete their combination in the fourth quarter of this year, Pfizer Chief Executive Officer Albert Bourla said during a conference call.

Mylan and Pfizer announced July 29, 2019 that they had agree to combine Mylan with Upjohn, Pfizer's off-patent branded and generic medicines business, to create

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News